Seelaus Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$268K Sell
3,230
-108
-3% -$8.96K 0.24% 131
2025
Q1
$271K Sell
3,338
-325
-9% -$26.4K 0.26% 121
2024
Q4
$330K Sell
3,663
-1,359
-27% -$122K 0.3% 105
2024
Q3
$496K Sell
5,022
-217
-4% -$21.4K 0.45% 69
2024
Q2
$486K Buy
5,239
+231
+5% +$21.4K 0.49% 63
2024
Q1
$475K Buy
5,008
+40
+0.8% +$3.8K 0.47% 71
2023
Q4
$444K Buy
4,968
+321
+7% +$28.7K 0.43% 81
2023
Q3
$339K Sell
4,647
-475
-9% -$34.7K 0.39% 91
2023
Q2
$426K Buy
5,122
+835
+19% +$69.4K 0.34% 105
2023
Q1
$349K Buy
4,287
+90
+2% +$7.33K 0.26% 122
2022
Q4
$348K Buy
4,197
+259
+7% +$21.5K 0.26% 127
2022
Q3
$312K Buy
3,938
+20
+0.5% +$1.59K 0.25% 135
2022
Q2
$291K Buy
3,918
+73
+2% +$5.42K 0.22% 144
2022
Q1
$346K Sell
3,845
-2,563
-40% -$231K 0.21% 156
2021
Q4
$717K Buy
6,408
+1,820
+40% +$204K 0.39% 73
2021
Q3
$577K Buy
4,588
+400
+10% +$50.3K 0.34% 89
2021
Q2
$567K Buy
4,188
+850
+25% +$115K 0.33% 100
2021
Q1
$453K Sell
3,338
-525
-14% -$71.2K 0.29% 109
2020
Q4
$544K Hold
3,863
0.39% 80
2020
Q3
$430K Hold
3,863
0.35% 89
2020
Q2
$432K Sell
3,863
-150
-4% -$16.8K 0.39% 81
2020
Q1
$311K Hold
4,013
0.37% 85
2019
Q4
$382K Sell
4,013
-66
-2% -$6.28K 0.31% 93
2019
Q3
$311K Sell
4,079
-190
-4% -$14.5K 0.27% 101
2019
Q2
$374K Hold
4,269
0.34% 84
2019
Q1
$387K Hold
4,269
0.36% 85
2018
Q4
$306K Buy
4,269
+35
+0.8% +$2.51K 0.33% 89
2018
Q3
$406K Sell
4,234
-750
-15% -$71.9K 0.33% 93
2018
Q2
$474K Sell
4,984
-550
-10% -$52.3K 0.41% 77
2018
Q1
$485K Buy
5,534
+78
+1% +$6.84K 0.42% 79
2017
Q4
$463K Buy
+5,456
New +$463K 0.4% 76